These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21500121)

  • 21. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens.
    Loo PS; Thomas SC; Nicolson MC; Fyfe MN; Kerr KM
    J Thorac Oncol; 2010 Apr; 5(4):442-7. PubMed ID: 20195168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The international multidisciplinary classification of lung adenocarcinoma from IASLC/ATS/ERS and problems in clinical practice].
    Yan L; Yi X
    Zhongguo Fei Ai Za Zhi; 2013 Jul; 16(7):333-8. PubMed ID: 23866662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IASLC/ATS/ERS International Multidisciplinary Classification of Lung Adenocarcinoma: novel concepts and radiologic implications.
    Lee HJ; Lee CH; Jeong YJ; Chung DH; Goo JM; Park CM; Austin JH
    J Thorac Imaging; 2012 Nov; 27(6):340-53. PubMed ID: 23086014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further evaluation of quantitative nuclear image features for classification of lung carcinomas.
    Thunnissen FB; Diegenbach PC; van Hattum AH; Tolboom J; van der Sluis DM; Schaafsma W; Houthoff HJ; Baak JP
    Pathol Res Pract; 1992 Jun; 188(4-5):531-5. PubMed ID: 1329052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Automated chromogenic multiplexed immunohistochemistry assay for diagnosis and predictive biomarker testing in non-small cell lung cancer.
    Ilie M; Beaulande M; Hamila M; Erb G; Hofman V; Hofman P
    Lung Cancer; 2018 Oct; 124():90-94. PubMed ID: 30268486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between molecular analysis, diagnosis according to the 2015 WHO classification of unresected lung tumours and TTF1 expression in small biopsies and cytology specimens from 344 non-small cell lung carcinoma patients.
    Russell PA; Rogers TM; Solomon B; Alam N; Barnett SA; Rathi V; Williams RA; Wright GM; Conron M
    Pathology; 2017 Oct; 49(6):604-610. PubMed ID: 28811082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid on-site evaluation has high diagnostic yield differentiating adenocarcinoma vs squamous cell carcinoma of non-small cell lung carcinoma, not otherwise specified subgroup.
    Celik B; Khoor A; Bulut T; Nassar A
    Pathol Oncol Res; 2015 Jan; 21(1):167-72. PubMed ID: 24889857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recommendation concerning the microscopic classification of lung adenocarcinoma presented by International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society].
    Langfort R; Szołkowska M
    Pneumonol Alergol Pol; 2012; 80(2):99-100. PubMed ID: 22370977
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum tumour markers in lung cancer.
    Hansen M
    Scand J Clin Lab Invest Suppl; 1991; 206():93-101. PubMed ID: 1658919
    [No Abstract]   [Full Text] [Related]  

  • 30. Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.
    Takahashi M; Shigematsu Y; Ohta M; Tokumasu H; Matsukura T; Hirai T
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):54-9. PubMed ID: 24131786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accuracy of classifying poorly differentiated non-small cell lung carcinoma biopsies with commonly used lung carcinoma markers.
    Zachara-Szczakowski S; Verdun T; Churg A
    Hum Pathol; 2015 May; 46(5):776-82. PubMed ID: 25776027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and treatment.
    Hiraki A; Ueoka H; Yoshino T; Chikamori K; Onishi K; Kiura K; Bessho A; Mimoto J; Date H; Ando A; Shimizu N; Harada M
    Oncol Rep; 1999; 6(1):75-80. PubMed ID: 9864405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P16 is a useful supplemental diagnostic marker of pulmonary small cell carcinoma in small biopsies and cytology specimens.
    Švajdler M; Mezencev R; Ondič O; Šašková B; Mukenšnábl P; Michal M
    Ann Diagn Pathol; 2018 Apr; 33():23-29. PubMed ID: 29566943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies.
    Warth A; Muley T; Herpel E; Meister M; Herth FJ; Schirmacher P; Weichert W; Hoffmann H; Schnabel PA
    Histopathology; 2012 Dec; 61(6):1017-25. PubMed ID: 22882703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification in stage IB lung adenocarcinoma.
    Xu CH; Wang W; Wei Y; Hu HD; Zou J; Yan J; Yu LK; Yang RS; Wang Y
    Eur J Surg Oncol; 2015 Oct; 41(10):1430-6. PubMed ID: 26123994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens.
    Nicholson SA; Beasley MB; Brambilla E; Hasleton PS; Colby TV; Sheppard MN; Falk R; Travis WD
    Am J Surg Pathol; 2002 Sep; 26(9):1184-97. PubMed ID: 12218575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should we continue to use the term non-small-cell lung cancer?
    Gazdar AF
    Ann Oncol; 2010 Oct; 21 Suppl 7(Suppl 7):vii225-9. PubMed ID: 20943619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can cytology reliably subtype non-small cell lung carcinomas?
    Jain D; Bubendorf L
    Cytopathology; 2022 Jan; 33(1):8-13. PubMed ID: 34494327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NSCLC Subtyping in Conventional Cytology: Results of the International Association for the Study of Lung Cancer Cytology Working Group Survey to Determine Specific Cytomorphologic Criteria for Adenocarcinoma and Squamous Cell Carcinoma.
    Jain D; Nambirajan A; Chen G; Geisinger K; Hiroshima K; Layfield L; Minami Y; Moreira AL; Motoi N; Papotti M; Rekhtman N; Russell PA; Prince SS; Schmitt F; Yatabe Y; Eppenberger-Castori S; Bubendorf L;
    J Thorac Oncol; 2022 Jun; 17(6):793-805. PubMed ID: 35331963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carcinoma NOS is a common histologic diagnosis and is increasing in proportion among non-small cell lung cancer histologies.
    Ou SH; Zell JA
    J Thorac Oncol; 2009 Oct; 4(10):1202-11. PubMed ID: 19701111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.